이 제품에 대해 글로벌 공급망 인텔리전스 네트워크에 수출업체 1,211개와 수입업체 1,172개가 색인되어 있습니다.
7,445건의 공급업체·제조사 연계 거래가 상위 20개 국가에 걸쳐 요약되어 있습니다.
프리미엄 공급업체·제조사 1개와 카탈로그 0건이 현재 등록되어 있습니다.
도매 샘플 항목: 0건; 산지가 샘플 항목: 0건.
이 페이지 데이터셋의 최신 기준 연도는 2024입니다.
페이지 데이터 최종 업데이트일: 2026-08-13.
액상 분유에 대한 글로벌 공급업체·제조사 거래, 수출 활동 및 가격 벤치마크
상위 20개 국가에 걸친 공급업체 연계 거래 7,445건을 분석하고, 월간 단가 벤치마크로 액상 분유의 수출 경쟁력과 소싱 리스크를 추적하세요.
액상 분유 국가별 공급업체 거래 및 수출 모멘텀 전년 대비 변화
액상 분유의 긍정적/부정적 전년 대비 변화를 비교해 성장하는 공급 시장과 약화되는 수출 경로를 식별하세요.
액상 분유의 YoY 변동 상위 국가는 미국 (+55.3%), 아르헨티나 (+48.6%), 네덜란드 (+44.4%)입니다.
액상 분유 국가별 공급업체 거래 및 단가 요약
2025-09 기준으로 액상 분유 국가별 거래 건수와 월간 단가/물량을 비교해 공급업체 및 수출 시장 우선순위를 정하세요.
2026-02 기준, 노출 가능한 액상 분유 거래 단가가 있는 국가는 뉴질랜드 (19.25 USD / kg), 네덜란드 (16.64 USD / kg), 스페인 (14.16 USD / kg), 독일 (11.82 USD / kg), 싱가포르 (11.19 USD / kg), 외 14개국입니다.
액상 분유의 원산지-도착지 무역 흐름을 금액, 물량, 점유율 기준으로 분석해 수요 측 소싱 채널을 모니터링하세요.
수출 진단
우리 액상 분유, 어느 바이어에게 팔 수 있을까요?
만드시는 제품만 알려주시면 됩니다. 지금 수출할 준비가 됐는지, 어느 시장이 맞는지 무료로 봐드려요.
가격 데이터
가려진 액상 분유 가격, 열어볼까요?
전체 가격 히스토리와 경쟁사 벤치마크를 열어드립니다. 어떤 숫자가 필요하신지만 말씀해 주시면 함께 살펴봐 드려요.
Classification
Product TypeProcessed Food
Product FormLiquid (Ready-to-Feed)
Industry PositionSpecialized Packaged Food (Infant Nutrition)
Market
Liquid (ready-to-feed) infant formula is a highly regulated dairy-based (or alternative-protein) packaged nutrition product used as a breast-milk substitute where needed, with global market access shaped by stringent safety, compositional, and labeling rules. At the HS-6 level, publicly available trade statistics do not cleanly isolate liquid formula from other infant preparations; HS 190110 is commonly used as a proxy category that includes infant formula and other infant foods put up for retail sale. Using this proxy, 2023 exports are led by European dairy-processing hubs (notably the Netherlands, France, Germany, and Ireland) and by New Zealand, while major import demand is concentrated in China and a set of high-import markets including Saudi Arabia, the United States, Canada, and Southeast Asia. Market dynamics are strongly influenced by brand trust, compliance documentation, and the high consequence of safety incidents (recalls, plant shutdowns) for continuity of supply.
Major Producing Countries
네덜란드Major manufacturing/export hub for infant nutrition products; UN Comtrade via WITS shows ~USD 2.41B exports under HS 190110 (proxy category) in 2023.
프랑스Major manufacturing/export base for infant nutrition; UN Comtrade via WITS shows ~USD 1.15B exports under HS 190110 (proxy category) in 2023.
독일Large-scale dairy processing and infant nutrition production; UN Comtrade via WITS shows ~USD 1.06B exports under HS 190110 (proxy category) in 2023.
아일랜드Export-oriented dairy ingredient and infant nutrition manufacturing; UN Comtrade via WITS shows ~USD 0.90B exports under HS 190110 (proxy category) in 2023.
뉴질랜드Significant exporter of infant nutrition preparations (notably dairy-based); UN Comtrade via WITS shows ~USD 1.08B exports under HS 190110 (proxy category) in 2023.
Major Exporting Countries
네덜란드Top exporter by value in 2023 under HS 190110 (proxy category): ~USD 2.41B (UN Comtrade via WITS).
프랑스Top exporter by value in 2023 under HS 190110 (proxy category): ~USD 1.15B (UN Comtrade via WITS).
뉴질랜드Top exporter by value in 2023 under HS 190110 (proxy category): ~USD 1.08B (UN Comtrade via WITS).
독일Top exporter by value in 2023 under HS 190110 (proxy category): ~USD 1.06B (UN Comtrade via WITS).
아일랜드Top exporter by value in 2023 under HS 190110 (proxy category): ~USD 0.90B (UN Comtrade via WITS).
Major Importing Countries
중국Largest importer by value in 2023 under HS 190110 (proxy category): ~USD 4.29B (UN Comtrade via WITS).
사우디아라비아Major importer by value in 2023 under HS 190110 (proxy category): ~USD 0.62B (UN Comtrade via WITS).
미국Major importer by value in 2023 under HS 190110 (proxy category): ~USD 0.35B (UN Comtrade via WITS).
캐나다Major importer by value in 2023 under HS 190110 (proxy category): ~USD 0.29B (UN Comtrade via WITS).
말레이시아Major importer by value in 2023 under HS 190110 (proxy category): ~USD 0.29B (UN Comtrade via WITS).
베트남Notable importer by value in 2023 under HS 190110 (proxy category): ~USD 0.27B (UN Comtrade via WITS).
Specification
Major VarietiesInfant formula (standard) — liquid ready-to-feed, Formulas for special medical purposes intended for infants — liquid ready-to-feed
Physical Attributes
Ready-to-feed liquid designed for direct consumption without reconstitution
Commercially sterile or aseptically packed formats are common for shelf-stable liquid products
Compositional Metrics
Compositional and nutrient suitability requirements are typically specified against Codex CXS 72-1981 and/or national infant formula regulations
Buyer specifications often emphasize nutrient profile targets (macro- and micronutrients), ingredient compliance, and documented clinical/nutritional adequacy where required
Packaging
Single-serve ready-to-feed bottles (often with compatible sterile nipples/caps depending on market)
Aseptic cartons (multi-serve) or multi-pack retail configurations
Tamper-evident closures and high-integrity packaging to protect sterility
ProcessingHigh-shear mixing and emulsification of fat/protein/carbohydrate phasesHomogenization to stabilize emulsionUHT/sterilization and aseptic filling for shelf-stable liquid formats (where used)Tight microbiological controls and environmental monitoring in high-hygiene zones
Infant feeding needs where breastfeeding is not possible or not chosen, including medically indicated use under professional guidance
Trust in safety/compliance and brand reputation in a high-consequence product category
Convenience-oriented demand for ready-to-feed formats in urban and travel use cases
Temperature
Unopened shelf-stable aseptic products are typically handled as ambient goods per label instructions; temperature abuse can still affect quality and packaging integrity
After opening, refrigeration and short in-use windows are typically required per label to reduce microbial risk
Shelf Life
Shelf life depends on formulation and packaging system; aseptic shelf-stable products generally have a long unopened shelf life, while opened product has a short safe-use window per label instructions
Risks
Food Safety HighInfant formula is a high-consequence food category where microbiological hazards and contamination events can trigger rapid recalls, import rejections, and plant shutdowns, disrupting supply and damaging trust. While ready-to-feed liquid products may be produced as commercially sterile/aseptic, failures in hygienic design, aseptic integrity, or post-process contamination controls can still create severe public-health and trade impacts; broader infant formula safety incidents (e.g., Cronobacter-linked investigations and recalls) show how quickly availability can be affected.Maintain validated thermal/aseptic processes, rigorous environmental monitoring and sanitation, strong supplier assurance, and crisis-ready recall and communication systems across all markets.
Regulatory Compliance HighCross-border trade is constrained by stringent and sometimes divergent national rules on composition, permitted additives, labeling/claims, and registration approvals for infant formula. Non-compliance can lead to detentions, withdrawals, and long re-approval cycles that are especially disruptive for specialized/medical formulas.Design to Codex-aligned baselines where feasible, maintain market-specific regulatory dossiers, and implement robust label/claims governance with pre-clearance.
Supply Concentration MediumManufacturing is capital-intensive and quality-critical, which concentrates supply in a relatively small number of qualified plants and multinationals. Disruptions at large facilities (quality incidents, equipment failures, regulatory actions) can create sudden shortfalls, particularly in markets reliant on imported brands or limited approved suppliers.Dual-source critical SKUs, qualify contingency plants, and maintain safety stock strategies tailored to shelf-stable logistics constraints.
Trade Data Ambiguity MediumCommodity-trade classifications at HS-6 (e.g., HS 190110) combine infant formula with other infant food preparations, limiting transparency on liquid ready-to-feed trade flows and complicating risk monitoring and market sizing for this specific product form.Use customs-line (HS-8/10) analysis and regulatory product registries where available to separate liquid formula from broader infant preparations.
Sustainability
Dairy supply-chain greenhouse gas footprint and the need for credible emissions accounting across upstream milk and energy-intensive processing
Packaging waste (single-serve plastic bottles, multilayer aseptic cartons) and recyclability constraints in many import markets
Vegetable-oil inputs in fat blends can create deforestation and traceability exposure (notably where palm-derived oils are used), increasing scrutiny of supplier certification and chain-of-custody
Labor & Social
Responsible marketing compliance risk tied to the WHO International Code of Marketing of Breast-milk Substitutes and related national implementations
Affordability and equitable access concerns during shortages or trade disruptions, with heightened sensitivity in emergency procurement contexts
Counterfeit/diverted product risk in cross-border and online channels, increasing the importance of track-and-trace and authorized distribution
FAQ
Which countries are the largest exporters in global trade data for infant formula-related preparations?Using HS 190110 (a proxy category that includes infant formula and other infant foods put up for retail sale), the top exporters by value in 2023 were the Netherlands, France, New Zealand, Germany, and Ireland (UN Comtrade via World Bank WITS).
What global standard is commonly referenced for infant formula composition and safety expectations?Codex Alimentarius CXS 72-1981 is a widely referenced global standard covering infant formula (including liquid and powdered forms) and formulas for special medical purposes intended for infants.
What is the single biggest global risk that can disrupt supply and trade of liquid infant formula?Food safety incidents are the most disruptive risk because they can trigger rapid recalls, import rejections, and plant shutdowns in a category with extremely low tolerance for contamination; official public-health and regulator investigations involving infant formula illustrate how quickly availability can be affected.